The gram-negative bacteria Escherichia coli and Sabnonella typhimurium contain a phosphoenolpyruvate-dependent sugar phosphotransferase system (PTS) which is active in the translocation and concomitant phosphorylation of a number of sugars (15) . The PTS consists of a number of protein components which catalyze the transfer ofphosphoryl groups from phosphoenolpyruvate to the sugar (Fig. 1) . In addition to their role in transport, some of these proteins have also been implicated in the regulation of cell metabolism. In particular, glucose-specific factor m (I1G1) or a closely related regulatory protein is thought to play a central role (15, 17, 20) . The regulatory role of the PTS is illustrated by the pleiotropic nature of mutants defective in one or more components of the PTS. E. coli or S. typhimurium mutant strains which lack enzyme I or HPr or both do not grow on a number of non-PTS sugars, including glycerol, melibiose, maltose, and lactose (see Table 2 ; for a review, see reference 15) . In E. coli this phenomenon has been attributed mainly to a low rate of cyclic AMP (cAMP) synthesis. There is evidence that the PTS is involved in regulation of adenylate cyclase activity, as suggested by the inhibition of adenylate cyclase activity by PTS sugars (7) . Phosphorylated enzyme I and a phosphorylated regulatory protein have been proposed as activators of adenylate cyclase (13, 17) .
For S. typhimurium, on the other hand, the inability of pts mutants to grow on many non-PTS carbon sources has been explained mainly on the basis of inducer exclusion (15, [18] [19] [20] . The non-phosphorylated form of a protein component of the PTS is thought to inhibit the transport systems for glycerol, melibiose, and maltose, preventing the entry ofthese substrates (inducers). It has been proposed that the primary effector of this inhibition is mGlc, a protein component of the PTS involved in transport of glucose via enzyme Hl-BGc (Fig. 1) . Support for this proposal has been provided by the isolation of crr mutants. The crr mutation lowers the activity of IIIGiC in the cell and at the same time restores growth of pts mutants on several non-PTS carbon sources (19; see also Table 2 ). The concept of this type ofinducer exclusion predicts that inhibition of the entry of inducer prevents induction and subsequent growth, irrespective of the presence of cAMP. In other words, if inducer exclusion is involved in the growth inhibition ofpts mutants on melibiose, glycerol, or maltose, one would not expect that cAMP would restore growth of these pts mutants.
In this paper we report that either cAMP or a mutation in the cAMP binding protein (crp*) is able to overcome the effect of pts mutations in S. typhimurium with respect to growth on some non-PTS compounds. In particular, our results show that inducer exclusion in ptsI mutants is abolished either by the addition of cAMP or by the introduction of a crp* mutation.
The consequences for the current concept of inducer exclusion are discussed. Mutations which modify the cAMP binding protein. We found other evidence indicating that cAMP is in some way involved in inducer exclusion. As described by Saier and Roseman (19) , growth defects ofpts mutants on various non-PTS compounds can be suppressed by a crr mutation. In these pts crr double mutants, the crr mutation results in a lowered IIIG1c level.
MATERIAlJS
Mutants containing only a crr mutation were constructed as described in Materials and Methods. These crr mutants did not grow on a number of non-PTS compounds, including xylose, VOL. 141, 1980 consumption was measured as described in the text. The reaction wa8started by the addition of 6 citrate, succinate, and malate, but grew nornally on all PTS sugars or on the non-PTS sugars glycerol, maltose, and melibiose ( Table 2) . Lack of growth on xylose, citrate, or succinate could be overcome by the addition of external cAMP (Table 2 ). For instance, PP782 (crr-306) doubled every 60 min on xylose in the presence of 5 mM cAMP, whereas no growth occurred in the absence of cAMP. Starting with these crr strains, we isolated suppressors of the crr mutation which allowed, in addition, pts mutants to grow on a number of non-NTS carbon sources. Revertants of crr strains were sought which regained the ability to grow on xylose, citrate, and succinate at the same time. Some of these revertants carried a mutation which mapped close to cysA and were shown to have regained iGic activity. These stains presumably acquired reversions in the crr gene, correcting the original crr mutation. A second class of revertants also exhibited the Crr+ phenotype, but the mutation did not map near cysA. Subsequent mapping showed that these mutations were localized close to cysG, being 15 (10, 12) . Strains containing both cya and the suppressor mutation (for instance, PP958 cya-502 crp*-771) are able to grow again on, for instance, mannitol or melibiose, carbon sources on which the cya strain does not grow (see also reference 22) . (iii) Figure 3 shows that this suppressor mutation caused a decrease in the binding affinity for cAMP as measured in a cell extract. The strain used was constructed by transducing the suppressor mutation into a cysG strain, eliminating the possibility that more than one mutation was involved. From these data we conclude that the suppressor mutation was in the crp gene; it will be designated crp* hereafter.
Strains carrying only the crp* mutation, for instance PP914, showed nonnal growth on all carbon sources tested ( Table 2 ), indicating that the cAMP binding protein was still functional although it had altered binding properties. Strains with a defective cAMP binding protein instead do not grow on any of these carbon sources (6, 10) .
Revertants have been isolated from several crr strains. Until now, in all such cases, the suppressor mutation was cotransducible with either cysG or cysA.
Effect of crp* on pts mutants. In view of the observed effects of cAMP on pts mutants, we decided to test whether the crp* mutation also affected the growth of pts mutants. The following results were found. (i) A crp* AptsHI double mutant was able to grow on glycerol or melibiose but not on maltose (Table 2) . These results resemble those from experiments with externally added cAMP. Oxidation of glycerol or melibiose was not inhibited by methyl a-glucoside in these strains, results similar to those obtained with these strains grown in the presence of cAMP. (ii) A strain carrying both the leaky ptsI17 mutation and a crp* mutation showed no inducer exclusion as measured by the effect of methyl a-glucoside on both glycerol oxidation (Fig. 2C ) and glycerol transport (Fig.  4) . Similar results were obtained when thiomethyl galactoside transport via the melibiose transport system was measured (data not shown). The crp* mutation did not abolish inducer exclusion by interfering with the synthesis of IIIGI,. Transport of methyl a-glucoside, a specific substrate of the IIlGc/II-BGlc system, was normal or even elevated in crp* strains compared with that in the crp+ parent (Fig. 5) . Finally, the crp* mutation did not result in constitutive synthesis of the transport system for glycerol or melibiose, as illustrated for glycerol in Fig. 6 . Cells grown in minimal medium with galactose as a carbon source did not take up glycerol, whereas growth on glycerol induced normal uptake. This means that there was a normal requirement for the inducer in the crp* strain. Fig. 2A and 4 ) cannot be explained by a mechanism acting only at the level of operon transcription.
These results urge us to combine inducer exclusion and regulation by cAMP and crp* in one model. Apparently, the crpj mutation and cAMP influence one of the conditions necesary for the occurrence of inducer exclusion. The most obvious explanation, namely that the crp* mutation interferes with the synthesis of the PTS proteins, in particular IlHc, can be rejected on the basis of the evidence presented in Table   4 2 and Fig. 5 In this paper we present data that shed some light on these difficulties. A mutation, crp*, is described that allowed pts mutants to grow on these non-PTS sugars. Surprisingly, the crp * mutation was isolated as a suppressor of a crr mutation which, by itself, is a suppressor of pts mutations. The results led us to the conclusion that the crp* mutation interfered with inducer exclusion in some way. The effect of the crp* mutation may be explained by assuming that it stimulated the adenylate cyclase activity. The involvement of the crp gene in the regulation of cAMP production and adenylate cyclase synthesis has been reported (3, 16) . Alternatively, the crp* mutation could alter the cAMP binding protein in such a way that it needed less cAMP
